Serge Bologna

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont et al. · The Lancet Oncology · 2011 · 530 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +8

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Christian Récher, Bertrand Coiffier, Corinne Haïoun et al. · The Lancet · 2011 · 356 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Richard Delarue, Hervé Tilly, Nicolas Mounier et al. · The Lancet Oncology · 2013 · 298 citations

Hematological Malignancy, Dose-dense Rituximab-chop, Standard Rituximab-chop +6

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger et al. · Blood · 2011 · 297 citations

Efficacy and Safety of Rasburicase (recombinant urate oxidase) for the Prevention and Treatment of Hyperuricemia During Induction Chemotherapy of Aggressive Non-Hodgkin’s Lymphoma: Results of the GRAAL1 (Groupe d’Etude des Lymphomes de l’Adulte Trial on Rasburicase Activity in Adult Lymphoma) Study

Bertrand Coiffier, Nicolas Mounier, Serge Bologna et al. · Journal of Clinical Oncology · 2003 · 238 citations